The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Rosario Pivonello(University of Naples Federico II), Annamaria Colao(Federico II University Hospital), Antongiulio Faggiano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Paolo Cappabianca(Federico II University Hospital), Gaetano Lombardi(University of Genoa), Monica De Leo(Federico II University Hospital), Maria Cristina De Martino(Erasmus MC), Steven W. J. Lamberts(Erasmus MC), Leo J. Hofland(Erasmus MC)
Cited by 326
Related Papers
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
|Endocrine Reviews|2004|1.3k
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Complications of Cushing's syndrome: state of the art
|The Lancet Diabetes & Endocrinology|2016|602
Nutritional recommendations for CoVID-19 quarantine
|European Journal of Clinical Nutrition|2020|548